AI assistant
Sending…
LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2011
Dec 27, 2011
32814_dirs_2011-12-27_b4f8b5bb-7b09-491a-9d5d-37991cdf721a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEXICON PHARMACEUTICALS, INC./DE (LXRX)
CIK: 0001062822
Period of Report: 2011-12-22
Reporting Person: SANDS ARTHUR T (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-12-22 | Common Stock | M | 25000 | $1.13 | Acquired | 810726 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-12-22 | Subscription Rights (Right to Buy) | $1.13 | M | 58525 | Disposed | 2011-12-22 | Common Stock (25000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 60000 | Indirect |
| Common Stock | 817500 | Indirect |
Footnotes
F1: Each subscription right reflects a basic subscription privilege entitling the holder to purchase 0.427175 shares of common stock and an oversubscription privilege entitling the holder to purchase additional shares of common stock under certain circumstances.